The Guaifenesin and Codeine Phosphat, cataloged under National Stock Number 6505-01-395-9997, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Kenwood Laboratories Bradley Pharm Inc Div. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-395-9997 |
| Primary Part Number | NDC00482-0440-01 |
| Item Name | Guaifenesin and Codeine Phosphat |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Kenwood Laboratories Bradley Pharm Inc Div |
| Status | ACTIVE |
| General Characteristics Item Description | 100 TABLETS PER BOTTLE; CONTAINS 300 MG GUAIFENESIN AND 10 MG CODEINE PHOSPHATE ACTIVE INGREDIENTS |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00482-0440-01 PRIMARY | Kenwood Laboratories Bradley Pharm Inc Div (USA) |
| Reference | Meaning |
|---|---|
| NDC00149-0441-01 | 5/9 Secondary reference Procter & Gamble Pharmaceuticals, Inc. |
| BRONTEX TABLETS | 5/1 Secondary reference Procter & Gamble Pharmaceuticals, Inc. |
| BRONTEX | 5/1 Secondary reference Procter & Gamble Pharmaceuticals, Inc. |
NSN 6505-01-395-9997 is a Guaifenesin and Codeine Phosphat, manufactured by Kenwood Laboratories Bradley Pharm Inc Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-395-9997 has 1 manufacturer part number on file: NDC00482-0440-01 (Kenwood Laboratories Bradley Pharm Inc Div).
Key specifications for NDC00482-0440-01: General Characteristics Item Description: 100 TABLETS PER BOTTLE; CONTAINS 300 MG GUAIFENESIN AND 10 MG CODEINE PHOSPHATE ACTIVE INGREDIENTS; Part Name Assigned by Controlling Agency: GUAIFENESIN AND CODEINE PHOSPHATE TABLETS 100S BT. 1 specification is documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.